250 related articles for article (PubMed ID: 19949027)
1. Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Pang VF; Liu RS; Lin WJ; Yang CS; Ting G
J Nucl Med; 2009 Dec; 50(12):2073-81. PubMed ID: 19949027
[TBL] [Abstract][Full Text] [Related]
2. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.
Lin YY; Li JJ; Chang CH; Lu YC; Hwang JJ; Tseng YL; Lin WJ; Ting G; Wang HE
Cancer Biother Radiopharm; 2009 Aug; 24(4):453-60. PubMed ID: 19694580
[TBL] [Abstract][Full Text] [Related]
4. Tumor burden talks in cancer treatment with PEGylated liposomal drugs.
Lin YY; Kao HW; Li JJ; Hwang JJ; Tseng YL; Lin WJ; Lin MH; Ting G; Wang HE
PLoS One; 2013; 8(5):e63078. PubMed ID: 23675454
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Pang VF; Wang SJ; Whang-Peng J; Ting G
Nucl Med Biol; 2008 Jul; 35(5):623-34. PubMed ID: 18589307
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine Plus
Chien YC; Chou YH; Wang WH; Chen JC; Chang WS; Tsai CW; Bau DT; Hwang JJ
Cancer Genomics Proteomics; 2020; 17(1):61-76. PubMed ID: 31882552
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.
Li C; Cui J; Wang C; Zhang L; Xiu X; Li Y; Wei N; Li Y; Zhang L
J Pharm Pharmacol; 2011 Mar; 63(3):376-84. PubMed ID: 21749385
[TBL] [Abstract][Full Text] [Related]
8. Correlation between radioactivity and chemotherapeutics of the (111)In-VNB-liposome in pharmacokinetics and biodistribution in rats.
Lee WC; Chang CH; Huang CM; Wu YT; Chen LC; Ho CL; Chang TJ; Lee TW; Tsai TH
Int J Nanomedicine; 2012; 7():683-92. PubMed ID: 22359447
[TBL] [Abstract][Full Text] [Related]
9. Monitoring Tumor Response after Liposomal Doxorubicin in Combination with Liposomal Vinorelbine Treatment Using 3'-Deoxy-3'-[
Wu CY; Tang JH; Chan PC; Li JJ; Lin MH; Shen CC; Liu RS; Wang HE
Mol Imaging Biol; 2017 Jun; 19(3):408-420. PubMed ID: 27730471
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models.
Lin YY; Chang CH; Li JJ; Stabin MG; Chang YJ; Chen LC; Lin MH; Tseng YL; Lin WJ; Lee TW; Ting G; Chang CA; Chen FD; Wang HE
Cancer Biother Radiopharm; 2011 Jun; 26(3):373-80. PubMed ID: 21711113
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model.
Chen LC; Chang CH; Yu CY; Chang YJ; Hsu WC; Ho CL; Yeh CH; Luo TY; Lee TW; Ting G
Nucl Med Biol; 2007 May; 34(4):415-23. PubMed ID: 17499731
[TBL] [Abstract][Full Text] [Related]
12. Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology.
Li CL; Cui JX; Wang CX; Zhang L; Li YH; Zhang L; Xiu X; Li YF; Wei N
Int J Pharm; 2010 May; 391(1-2):230-6. PubMed ID: 20214962
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
14. Monitoring tumor response with [18F]FMAU in a sarcoma-bearing mouse model after liposomal vinorelbine treatment.
Chan PC; Wu CY; Chang WT; Lin CY; Tseng YL; Liu RS; Alauddin MM; Lin WJ; Wang HE
Nucl Med Biol; 2013 Nov; 40(8):1035-42. PubMed ID: 23969084
[TBL] [Abstract][Full Text] [Related]
15. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer.
Li XT; Zhou ZY; Jiang Y; He ML; Jia LQ; Zhao L; Cheng L; Jia TZ
J Drug Target; 2015 Apr; 23(3):232-43. PubMed ID: 25417934
[TBL] [Abstract][Full Text] [Related]
16. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC.
Pal K; Madamsetty VS; Dutta SK; Mukhopadhyay D
Int J Nanomedicine; 2019; 14():5109-5123. PubMed ID: 31371950
[TBL] [Abstract][Full Text] [Related]
18. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pegylated and non-pegylated liposomal formulation for the delivery of hypoxia activated vinblastine-N-oxide for the treatment of solid tumors.
Shah VM; Nguyen DX; Alfatease A; Bracha S; Alani AW
J Control Release; 2017 May; 253():37-45. PubMed ID: 28302582
[TBL] [Abstract][Full Text] [Related]
20. A near-infrared two-photon-sensitive peptide-mediated liposomal delivery system.
Yang Y; Yang Y; Xie X; Cai X; Wang Z; Gong W; Zhang H; Li Y; Mei X
Colloids Surf B Biointerfaces; 2015 Apr; 128():427-438. PubMed ID: 25766920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
